FHIR IG analytics| Package | ke.fhir.nccp |
| Resource Type | MedicationStatement |
| Id | MedicationStatement-PriorSystemicTherapyStatementExample.json |
| FHIR Version | R4 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
5 years of adjuvant tamoxifen for ER+ breast cancer (2018–2023) prior to current recurrence
{
"resourceType": "MedicationStatement",
"id": "PriorSystemicTherapyStatementExample",
"meta": {
"profile": [
"https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-prior-systemic-therapy-statement"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"status": "completed",
"category": {
"coding": [
{
"system": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs",
"code": "HORMONAL-THERAPY",
"display": "Hormonal Therapy"
}
]
},
"medicationCodeableConcept": {
"coding": [
{
"system": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs",
"code": "TAMOXIFEN",
"display": "Tamoxifen"
}
]
},
"subject": {
"reference": "Patient/example-patient"
},
"effectivePeriod": {
"start": "2018-03-01",
"end": "2023-02-28"
},
"reasonReference": [
{
"reference": "Condition/example-condition"
}
],
"note": [
{
"text": "Completed 5 years of adjuvant tamoxifen. Switched to letrozole following menopause in 2021."
}
]
}